Blood Pressure

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93